TREATMENT OF PARKINSONS-DISEASE WITH BROMOCRIPTINE - REPLY

被引:0
|
作者
LIEBERMAN, AN [1 ]
机构
[1] NYU,MED CTR,NEW YORK,NY 10003
来源
NEW ENGLAND JOURNAL OF MEDICINE | 1977年 / 297卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:508 / 509
页数:2
相关论文
共 50 条
  • [31] MENTAL DISTURBANCES DURING BROMOCRIPTINE AND LERGOTRILE TREATMENT OF PARKINSONS-DISEASE
    SERBY, M
    ANGRIST, B
    LIEBERMAN, A
    AMERICAN JOURNAL OF PSYCHIATRY, 1978, 135 (10): : 1227 - 1229
  • [32] NEUROPSYCHIATRIC SIDE-EFFECTS OF BROMOCRIPTINE IN THE TREATMENT OF PARKINSONS-DISEASE
    SIMONETTA, M
    SCHMITT, L
    MONTASTRUC, JL
    RASCOL, A
    REVUE NEUROLOGIQUE, 1987, 143 (8-9) : 608 - 611
  • [33] PHARMACOKINETICS OF BROMOCRIPTINE DURING CONTINUOUS ORAL TREATMENT OF PARKINSONS-DISEASE
    FRIIS, ML
    GRON, U
    LARSEN, NE
    PAKKENBERG, H
    HVIDBERG, EF
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 15 (04) : 275 - 280
  • [34] PARKINSONS-DISEASE - REPLY
    MARSDEN, CD
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 58 (03): : 392 - 392
  • [35] PARKINSONS-DISEASE - REPLY
    PINCUS, JH
    BARRY, K
    ARCHIVES OF NEUROLOGY, 1988, 45 (07) : 716 - 716
  • [37] FETAL HOMOTRANSPLANTS IN THE TREATMENT OF PARKINSONS-DISEASE - REPLY
    MADRAZO, I
    FRANCOBOURLAND, R
    ARCHIVES OF NEUROLOGY, 1991, 48 (09) : 901 - 902
  • [38] THE INFLUENCE OF LEVODOPA IN THE PHARMACOKINETICS OF BROMOCRIPTINE IN PARKINSONS-DISEASE
    RABEY, JM
    OBERMAN, Z
    SCHARF, M
    ISAKOV, A
    BAR, M
    GRAFF, E
    CLINICAL NEUROPHARMACOLOGY, 1989, 12 (05) : 440 - 447
  • [39] THE INFLUENCE OF BROMOCRIPTINE ON THE PHARMACOKINETICS OF LEVODOPA IN PARKINSONS-DISEASE
    RABEY, JM
    SCHWARTZ, M
    GRAFF, E
    HARSAT, A
    VERED, Y
    CLINICAL NEUROPHARMACOLOGY, 1991, 14 (06) : 514 - 522
  • [40] BROMOCRIPTINE IN PARKINSONS-DISEASE - A STUDY OF CARDIOVASCULAR EFFECTS
    QUINN, N
    ILLAS, AC
    LHERMITTE, F
    AGID, Y
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1981, 44 (05): : 426 - 429